Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action

Journal of Peptide Science

Volumn 15, Issue 5, 2009, Pages 345-352

  Long Zhu, Wan Long ^a   Shin, Song Yub ^a,b  

^a Chosun University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Bactericidal mechanism; Cell penetrating peptide; Dimerization; Tat (48 60)

Indexed keywords

CALCEIN; CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE TAT [48-60] DERIVATIVE; DIOLEOYLPHOSPHATIDYLGLYCEROL; LYSINE; PHOSPHATIDYLETHANOLAMINE; POLYPEPTIDE ANTIBIOTIC AGENT; TAT [W] C PEPTIDE; TAT [W] K PEPTIDE; TAT [W] PEPTIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PEPTIDE FRAGMENT; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE PERMEABILITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; EGG YOLK; ESCHERICHIA COLI; HEMOLYSIS; LIPID BILAYER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; CHEMISTRY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; GENE PRODUCTS, TAT; HEMOLYSIS; HUMANS; KINETICS; LIPID BILAYERS; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; STAPHYLOCOCCUS AUREUS;

EID: 67649234630     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1120     Document Type: Article

References (32)

1. Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 1993; 61: 2978-2984.
2. Skerlavaj B,Romeo D,Gennaro R. Rapid membrane permeabilization and inhibition of vital functions of Gram-negative bacteria by bactenecins. Infect. Immun. 1990; 58: 3724-3730.
3. Sadler K, Eom KD, Yang JL, Dimitrova Y, Tam JP. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry 2002; 41: 14150-14157.
4. Zhao M, Weissleder R. Intracellular cargo delivery using tat peptide and derivatives. Med. Res. Rev. 2004; 24: 1-12.
5. Tünnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J. 2006; 20: 1775-1784.
6. Jung HJ, Park Y, Hahm K-S, Lee DG. Biological activity of Tat (47-58) peptide on human pathogenic fungi. Biochem. Biophys. Res. Commun. 2006; 345: 222-228.
7. Jung HJ, Jeong K-S, Lee DG. Effective antibacterial action of Tat (47-58) by increased uptake into bacterial cells in the presence of trypsin. J. Microbiol. Biotechnol. 2008; 18: 990-996.
8. Epand RF, Lehrer RT, Wang W, Maget-Dana R, Lelievre D, Epand RM. Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues. Biopolymers 2003; 71: 2-16.
9. Song YM, Yang ST, Lim SS, Kim Y, Hahm KS, Kim JI, Shin SY. Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic α-helical model peptide on structure and cell selectivity. Biochem. Biophys. Res. Commun. 2004; 314: 615-621.
10. Chan DI, Prenner EJ, Vogel HJ. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 2006; 1758: 1184-1202.
11. Schibli DJ, Epand RF, Vogel HJ, Epand RM. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell Biol. 2002; 80: 667-677.
12. Pan Y, Wan J, Roginski H, Lee A, Shiell B, Michalski WP, Coventry MJ. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin. Lett. Appl. Microbiol. 2007; 44: 229-234.
13. Thorén PE, Persson D, Isakson P, Goksör M, Onfelt A, Nordén B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 2003; 307: 100-107.
14. Thorén PE, Persson D, Esbjörner EK, Goksör M, Lincoln P, Nordén B. Membrane binding and translocation of cell-penetrating peptides. Biochemistry 2004; 43: 3471-3489.
15. Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY. Effects of Pro → peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide. Biochemistry 2006; 45: 13007-13017.
16. Mao D, Wallace BA. Differential light scattering and absorption flattening optical effects areminimal in the circular dichroism spectra of small unilamellar vesicles. Biochemistry 1984; 23: 2667-2673.
17. Barlett CR. Phosphorus assay in column chromatography. J. Biol. Chem. 1959; 234: 466-468.
18. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000; 44: 2086-2092.
19. Kobayashi S, Takeshima K,Park CB, Kim SC, Matsuzaki K. Interactions of the novel antimicrobial peptide buforin II with lipid bilayers: proline as a translocation promoting factor. Biochemistry 2000; 39: 8648-8654.
20. Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem. Biophys. Res. Commun. 2006; 349: 769-774.
21. Zhang L, Rozek A, Hancock RE. Interaction of cationic antimicrobial peptides with model Membranes. J. Biol. Chem. 2001; 276: 35714-35722.
22. Giangaspero A, Sandri L, Tossi A. Amphipathic α-helical antimicrobial peptides. Eur. J. Biochem. 2001; 268: 5589-5600.
23. Tossi A, Sandri L, Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 2000; 55: 4-30.
24. Zhu WL, Song YM, Park Y, Park KH, Yang ST, Kim JI, Park IS, Hahm KS, Shin SY. Substitution of the leucine zipper sequence inmelittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim. Biophys. Acta 2007; 768: 1506-1517.
25. Jang WS, Kim KN, Lee YS, Nam MH, Lee IH. Halocidin: A new antimicrobial peptide from hemocytes of the solitary tunicate Halocynthia aurantium. FEBS Lett. 2002; 521: 81-86.
26. Batista CV, Scaloni A, Rigden DJ, Silva LR, Rodrigues Romero A, Dukor R, Sebben A, Talamo F, Bloch C. A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta. FEBS Lett. 2001; 494: 85-89.
27. Lee IH, Lee YS, Kim CH, Kim CR, Hong T, Menzel L, Boo LM, Pohl J, Sherman MA, Waring A, Lehrer RI. Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate Halocynthia aurantium. Biochim. Biophys. Acta 2001; 1527: 141-148.
28. Dempsey CE, Ueno S, Avison MB. Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue. Biochemistry 2003; 42: 402-409.
29. Tencza SB, Creighton DJ, Yuan T, Vogel HJ, Montelaro RC, Mietzner TA. Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. J. Antimicrob. Chemother. 1999; 44: 33-41.
30. Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 8245-8250.
31. Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 2005; 44: 12094-12106.
32. Park KH, Park Y, Park IS, Hahm KS, Shin SY. Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides. J. Pept. Sci. 2008; 14: 876-882.